The neo-liberal transformation of global economy has brought in a new trade regime replacing GATT 1947 with incorporation of services and intellectual property in the products to be exchanged and WTO as its powerful regulator. Health being one of the services has become tradable for the first time. India has chosen to engage in health trade substantially to drive economic benefits from medical tourism, export of pharmaceuticals and manpower, and to carry out contract clinical trials. This has resulted in a paradigm shift in the role of state in the provisioning of health services with very adverse implications for the access of poor to the health care services and quality of public health system. India should therefore firmly oppose further liberalization of health sector in any future negotiations in the WTO.